| Nov 11 |
CRISPR, Beam, other gene editing names up significantly
|
| Nov 11 |
Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism
|
| Nov 8 |
Elon Musk will be 'vitally important' in Trump admin: Cathie Wood
|
| Nov 7 |
CRISPR Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference
|
| Nov 7 |
CRISPR Therapeutics AG (NASDAQ:CRSP) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
|
| Nov 6 |
Wall Street Analysts See a 62.75% Upside in CRISPR Therapeutics (CRSP): Can the Stock Really Move This High?
|
| Nov 6 |
CRSP's Q3 Loss Narrower Than Expected, Sales Miss Estimates
|
| Nov 5 |
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates
|
| Nov 5 |
CRISPR Therapeutics GAAP EPS of -$1.01 beats by $0.37
|
| Nov 5 |
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
|
